NYSEAMERICAN:XXII - 22nd Century Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.37 +0.14 (+6.28 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$2.37
Today's Range$2.25 - $2.48
52-Week Range$1.92 - $4.44
Volume2.61 million shs
Average Volume1.81 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Receive XXII News and Ratings via Email

Sign-up to receive the latest news and ratings for XXII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSEAMERICAN:XXII
CUSIPN/A
Phone+1-716-2701523

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees79
OptionableOptionable

22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSEAMERICAN:XXII) posted its earnings results on Wednesday, November, 7th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter. The biotechnology company earned $6.26 million during the quarter. View 22nd Century Group's Earnings History.

When is 22nd Century Group's next earnings date?

22nd Century Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for 22nd Century Group.

What price target have analysts set for XXII?

1 Wall Street analysts have issued 1 year price targets for 22nd Century Group's shares. Their predictions range from $11.50 to $11.50. On average, they expect 22nd Century Group's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 385.2% from the stock's current price. View Analyst Price Targets for 22nd Century Group.

What is the consensus analysts' recommendation for 22nd Century Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for 22nd Century Group.

Has 22nd Century Group been receiving favorable news coverage?

News coverage about XXII stock has been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. 22nd Century Group earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future.

Are investors shorting 22nd Century Group?

22nd Century Group saw a increase in short interest in December. As of December 31st, there was short interest totalling 17,065,984 shares, an increase of 3.1% from the December 14th total of 16,545,424 shares. Based on an average daily trading volume, of 1,575,192 shares, the days-to-cover ratio is presently 10.8 days. Currently, 15.7% of the company's shares are sold short. View 22nd Century Group's Current Options Chain.

Who are some of 22nd Century Group's key competitors?

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the folowing people:
  • Mr. Henry Sicignano III, Pres, CEO & Director (Age 50)
  • Mr. John T. Brodfuehrer, CFO & Treasurer (Age 60)
  • Mr. Thomas L. James Esq., VP, Gen. Counsel & Sec. (Age 59)
  • James Vail, Director of Communications
  • Dr. Paul J. Rushton, VP of Plant Biotechnology (Age 55)

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $2.37.

What is 22nd Century Group's official website?

The official website for 22nd Century Group is http://www.xxiicentury.com/.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.


MarketBeat Community Rating for 22nd Century Group (NYSEAMERICAN XXII)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  232 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  438
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe XXII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XXII will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel